Private Advisor Group
RVMD icon

Private Advisor Group’s Revolution Medicines RVMD Stock Holding History

Private Advisor Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$920 Buy
+100
New +$19.8K ﹤0.01% 3176

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Private Advisor Group's RVMD Position: Q3 2026 in Review

Private Advisor Group opened a new position in Revolution Medicines (RVMD) in Q3 2026: 7,943 shares worth $1.63M. The stake represents 0.01% of the portfolio and ranks #1332 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in RVMD as recently as Q1 2026.

Private Advisor Group first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 405 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Private Advisor Group held 7,943 shares of Revolution Medicines worth $1.63M as of Q3 2026.
  • Revolution Medicines was a new Private Advisor Group position in Q3 2026.
  • Revolution Medicines made up 0.01% of Private Advisor Group's portfolio in Q3 2026, its #1332 holding.
  • Private Advisor Group first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 405 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.